ANDA 70942, held by Quantum Pharmics. Trazodone Hydrochloride.
As of Nov 16, 2026, ANDA 70942 (Trialodine), held by Quantum Pharmics, was not approved, with 2 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Trialodine50MG ยท tablet;oral | Trazodone Hydrochloride | Discontinued |
| Jun 12, 1987 | Supplement 2Manufacturing | Approved | None posted |
| Jun 12, 1987 | Supplement 3Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters